BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 32245401)

  • 41. Is mucosal healing more common than clinical remission in ulcerative colitis? - Is it the truth or only a myth coming from the studies?
    Rutka M; Milassin Á; Szepes Z; SzŰcs M; Nyári T; Bálint A; Bor R; Molnár T; Farkas K
    Scand J Gastroenterol; 2015 Aug; 50(8):985-90. PubMed ID: 25733077
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Twice-daily Budesonide 2-mg Foam Induces Complete Mucosal Healing in Patients with Distal Ulcerative Colitis.
    Naganuma M; Aoyama N; Suzuki Y; Nishino H; Kobayashi K; Hirai F; Watanabe K; Hibi T
    J Crohns Colitis; 2016 Jul; 10(7):828-36. PubMed ID: 26577683
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness of sigmoidoscopy for assessing ulcerative colitis disease activity and therapeutic response.
    Lin WC; Chang CW; Chen MJ; Hsu TC; Wang HY
    Medicine (Baltimore); 2019 May; 98(21):e15748. PubMed ID: 31124958
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: rapid symptom resolution and improvements in quality of life.
    Probert CS; Dignass AU; Lindgren S; Oudkerk Pool M; Marteau P
    J Crohns Colitis; 2014 Mar; 8(3):200-7. PubMed ID: 24012063
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mucosal concentrations of N-acetyl-5-aminosalicylic acid related to endoscopic activity in ulcerative colitis patients with mesalamine.
    Fukuda T; Naganuma M; Takabayashi K; Hagihara Y; Tanemoto S; Nomura E; Yoshimatsu Y; Sugimoto S; Nanki K; Mizuno S; Mikami Y; Fukuhara K; Sujino T; Mutaguchi M; Inoue N; Ogata H; Iwao Y; Abe T; Kanai T
    J Gastroenterol Hepatol; 2020 Nov; 35(11):1878-1885. PubMed ID: 32250471
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trefoil Factor 3 is Highly Predictive of Complete Mucosal Healing Independently and in Combination with C-Reactive Protein in Patients with Ulcerative Colitis.
    Nakov R; Velikova T; Nakov V; Gerova V; Tankova L
    J Gastrointestin Liver Dis; 2019 Jun; 28():169-174. PubMed ID: 31204414
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mucosal Healing in Ulcerative Colitis--When Zero is Better.
    Boal Carvalho P; Dias de Castro F; Rosa B; Moreira MJ; Cotter J
    J Crohns Colitis; 2016 Jan; 10(1):20-5. PubMed ID: 26438714
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Complete mucosal healing defined by endoscopic Mayo subscore still demonstrates abnormalities by novel high definition colonoscopy and refined histological gradings.
    Iacucci M; Fort Gasia M; Hassan C; Panaccione R; Kaplan GG; Ghosh S; Gui X
    Endoscopy; 2015 Aug; 47(8):726-34. PubMed ID: 25826276
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mucosal gene transcription of ulcerative colitis in endoscopic remission.
    Arkteg CB; Goll R; Gundersen MD; Anderssen E; Fenton C; Florholmen J
    Scand J Gastroenterol; 2020 Feb; 55(2):139-147. PubMed ID: 31918598
    [No Abstract]   [Full Text] [Related]  

  • 50. Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis.
    Mak WY; Buisson A; Andersen MJ; Lei D; Pekow J; Cohen RD; Kahn SA; Pereira B; Rubin DT
    Dig Dis Sci; 2018 May; 63(5):1294-1301. PubMed ID: 29468374
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes.
    Christensen B; Hanauer SB; Erlich J; Kassim O; Gibson PR; Turner JR; Hart J; Rubin DT
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1557-1564.e1. PubMed ID: 28238954
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serial semi-quantitative measurement of fecal calprotectin in patients with ulcerative colitis in remission.
    Garcia-Planella E; Mañosa M; Chaparro M; Beltrán B; Barreiro-de-Acosta M; Gordillo J; Ricart E; Bermejo F; García-Sánchez V; Piqueras M; Llaó J; Gisbert JP; Cabré E; Domènech E;
    Scand J Gastroenterol; 2018 Feb; 53(2):152-157. PubMed ID: 29189092
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and efficacy of sodium hyaluronate (IBD98E) in the induction of clinical and endoscopic remission in subjects with distal ulcerative colitis.
    Fiorino G; Gilardi D; Naccarato P; Sociale OR; Danese S
    Dig Liver Dis; 2014 Apr; 46(4):330-4. PubMed ID: 24462118
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Definition and evaluation of mucosal healing in clinical practice.
    Mazzuoli S; Guglielmi FW; Antonelli E; Salemme M; Bassotti G; Villanacci V
    Dig Liver Dis; 2013 Dec; 45(12):969-77. PubMed ID: 23932331
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors associated with mucosal healing in patients with ulcerative colitis in clinical remission.
    Shi HY; Chan FK; Tsang SW; Hui YT; Sze SF; Ching JY; Chung T; Iu CY; Lo FH; Shan EH; Li MK; Wu JC; Sung JJ; Ng SC
    Inflamm Bowel Dis; 2015 Apr; 21(4):840-6. PubMed ID: 25738375
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Ulcerative Colitis Endoscopic Index of Severity More Accurately Reflects Clinical Outcomes and Long-term Prognosis than the Mayo Endoscopic Score.
    Ikeya K; Hanai H; Sugimoto K; Osawa S; Kawasaki S; Iida T; Maruyama Y; Watanabe F
    J Crohns Colitis; 2016 Mar; 10(3):286-95. PubMed ID: 26581895
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potential utility of a new ulcerative colitis segmental endoscopic index combining disease severity and the extent of inflammation.
    Suzuki Y; Uchiyama K; Kato M; Matsuo K; Nakagawa T; Kishikawa H; Kimura N; Kasanuki J; Ino S
    J Clin Gastroenterol; 2015; 49(5):401-6. PubMed ID: 25127112
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Are faecal markers good indicators of mucosal healing in inflammatory bowel disease?
    Boon GJ; Day AS; Mulder CJ; Gearry RB
    World J Gastroenterol; 2015 Oct; 21(40):11469-80. PubMed ID: 26523111
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Usefulness of fecal calprotectin for the early prediction of short-term outcomes of remission-induction treatments in ulcerative colitis in comparison with two-item patient-reported outcome.
    Toyonaga T; Kobayashi T; Nakano M; Saito E; Umeda S; Okabayashi S; Ozaki R; Hibi T
    PLoS One; 2017; 12(9):e0185131. PubMed ID: 28934315
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prostaglandin E-major urinary metabolite as a reliable surrogate marker for mucosal inflammation in ulcerative colitis.
    Arai Y; Arihiro S; Matsuura T; Kato T; Matsuoka M; Saruta M; Mitsunaga M; Matsuura M; Fujiwara M; Okayasu I; Ito S; Tajiri H
    Inflamm Bowel Dis; 2014 Jul; 20(7):1208-16. PubMed ID: 24846719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.